Literature DB >> 17652743

Responses of human lens epithelial cells to quercetin and DMSO.

Xiao-Guang Cao1, Xiao-Xin Li, Yong-Zhen Bao, Nian-Zeng Xing, Yi Chen.   

Abstract

PURPOSE: Oxidative stress is an initiating factor in the development of maturity-onset cataract. Diet has a significant impact on cataract development, and individual dietary components responsible for the protective effect include flavonoids, of which quercetin is the most important. The purpose of this study was to investigate the protective effect of quercetin and its toxicity for human lens epithelial cells (HLECs).
METHODS: HLECs in culture were incubated for 48 hours with either 1% (vol/vol) dimethyl sulfoxide (DMSO) alone or with this concentration of DMSO and between 0.1 and 100 microM of quercetin. Nonstimulated cells served as control cultures. The viability of HLECs was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) colorimetric assay. Gene expression was assessed with reverse transcription-polymerase chain reaction (RT-PCR). Cellular apoptosis was examined by in situ immunocytochemistry using terminal deoxynucleotidyl transferase-mediated biotin-dUTP nicked labeling (TUNEL) and by flow cytometry, using annexin V-FITC apoptosis detection.
RESULTS: DMSO (1% vol/vol) decreased cell viability, increased cellular apoptosis, and upregulated Bax in these cells; 0.1 microM quercetin inhibited these effects and protected HLECs from the toxicity of DMSO. Higher concentrations of quercetin the viability of HLECs decreased. In a dose-dependent response to quercetin, cellular apoptosis increased and the change correlated with upregulation of Bax and decreased cell viability.
CONCLUSIONS: Quercetin, at a low concentration (0.1 microM), protects HLECs and reverses the toxic effects of DMSO (1% vol/vol). However, at higher concentrations, quercetin is toxic to HLECs with an LD(50) of 90.85 microM. Quercetin induced apoptosis and upregulates apoptotic genes in HLECs in a dose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652743     DOI: 10.1167/iovs.06-1304

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice.

Authors:  Xiaoguang Cao; Melissa Liu; Jingsheng Tuo; Defen Shen; Chi-Chao Chan
Journal:  Exp Eye Res       Date:  2010-03-31       Impact factor: 3.467

2.  Fast loading ester fluorescent Ca2+ and pH indicators into pollen of Pyrus pyrifolia.

Authors:  Haiyong Qu; Xueting Jiang; Zebin Shi; Lianmei Liu; Shaoling Zhang
Journal:  J Plant Res       Date:  2011-07-26       Impact factor: 2.629

Review 3.  Potential of the bioflavonoids in the prevention/treatment of ocular disorders.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  J Pharm Pharmacol       Date:  2010-08       Impact factor: 3.765

4.  Inhibition of p300 and nuclear factor-kappaB by curcumin and its role in diabetic nephropathy.

Authors:  Biji T Kurien
Journal:  Nutrition       Date:  2009-09       Impact factor: 4.008

5.  Effects of benzene, quercetin, and their combination on porcine ovarian cell proliferation, apoptosis, and hormone release.

Authors:  Adam Tarko; Aneta Štochmal'ová; Katarína Jedličková; Sandra Hrabovszká; Adriana Vachanová; Abdel Halim Harrath; Saleh Alwasel; Abdulkarem Alrezaki; Jan Kotwica; Andrej Baláži; Alexander V Sirotkin
Journal:  Arch Anim Breed       Date:  2019-06-14

6.  Depigmenting effect of Kojic acid esters in hyperpigmented B16F1 melanoma cells.

Authors:  Ahmad Firdaus B Lajis; Muhajir Hamid; Arbakariya B Ariff
Journal:  J Biomed Biotechnol       Date:  2012-10-02

7.  Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature.

Authors:  Jesse S Pelletier; Kevin P Stewart; Kara Capriotti; Joseph A Capriotti
Journal:  Ophthalmol Ther       Date:  2015-11-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.